ConductScience.org, home

Trial · NCT07899944

Acupuncture Combined With Transcutaneous Electrical Acupoint Stimulation for Constipation-Predominant Irritable Bowel Syndrome With Anxiety State

NCT07899944, Not applicable, Not yet recruiting, The First Affiliated Hospital of Zhejiang Chinese Medical University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Acupuncture Combined With Transcutaneous Electrical Acupoint Stimulation for Constipation-Predominant Irritable Bowel Syndrome With Anxiety State. Trials, record NCT07899944. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07899944

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Acupuncture Combined With Transcutaneous Electrical Acupoint Stimulation for Constipation-Predominant Irritable Bowel Syndrome With Anxiety State
NCT number
NCT07899944
Status
Not yet recruiting
Phases
Not applicable
Enrollment
58 participants, estimated
Lead sponsor
The First Affiliated Hospital of Zhejiang Chinese Medical University
Conditions
IBS, Constipation Predominant, Anxiety State
Interventions
Acupuncture, Transcutaneous Electrical Acupoint Stimulation, Sham Transcutaneous Electrical Acupoint Stimulation
First posted
2026-10-28
Last updated
2026-10-28

Source ClinicalTrials.gov

Registered outcomes33

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryWeekly complete spontaneous bowel movements (CSBM)Week 4The number of complete spontaneous bowel movements recorded in the final observation week of intervention period.
SecondaryChange in Hospital Anxiety and Depression Scale-Anxiety subscale (HADS-A) scoreBaseline, Week 4Anxiety symptoms assessed using the Anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A). Total score ranges from 0 to 21; higher scores indicate more severe anxiety symptoms.
SecondaryChange in Hospital Anxiety and Depression Scale-Anxiety subscale (HADS-A) score at Week 5Baseline, Week 5Anxiety symptoms assessed using the Anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A). Total score ranges from 0 to 21; higher scores indicate more severe anxiety symptoms.
SecondaryChange in Hospital Anxiety and Depression Scale-Anxiety subscale (HADS-A) score at Week 8Baseline, Week 8Anxiety symptoms assessed using the Anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A). Total score ranges from 0 to 21; higher scores indicate more severe anxiety symptoms.
SecondaryChange in Hospital Anxiety and Depression Scale-Depression subscale (HADS-D) scoreBaseline, Week 4
Depressive symptoms assessed using the 7-item Depression subscale of the Hospital Anxiety and Depression Scale (HADS-D). Total score ranges from 0 to 21; higher scores indicate more severe depressive symptoms.
SecondaryChange in Hospital Anxiety and Depression Scale-Depression subscale (HADS-D) score at Week 8Baseline, Week 8
Depressive symptoms assessed using the 7-item Depression subscale of the Hospital Anxiety and Depression Scale (HADS-D). Total score ranges from 0 to 21; higher scores indicate more severe depressive symptoms.
SecondaryChange in Hospital Anxiety and Depression Scale Total score (HADS-Total)Baseline, Week 4
Total emotional status evaluated by the total score of Hospital Anxiety and Depression Scale, summing HADS-A and HADS-D subscale scores. Total score ranges from 0 to 42, higher scores indicate more severe emotional distress.
SecondaryChange in Hospital Anxiety and Depression Scale Total score (HADS-Total) at Week 8Baseline, Week 8
Total emotional status evaluated by the total score of Hospital Anxiety and Depression Scale, summing HADS-A and HADS-D subscale scores. Total score ranges from 0 to 42, higher scores indicate more severe emotional distress.
SecondaryChange in Pittsburgh Sleep Quality Index (PSQI) total scoreBaseline, Week 4Sleep quality assessed using the Pittsburgh Sleep Quality Index (PSQI). Total score ranges from 0 to 21; higher scores indicate poorer sleep quality.
SecondaryChange in Pittsburgh Sleep Quality Index (PSQI) total score at Week 8Baseline, Week 8Sleep quality assessed using the Pittsburgh Sleep Quality Index (PSQI). Total score ranges from 0 to 21; higher scores indicate poorer sleep quality.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07899944

GET https://conductscience.org/api/trials/v1/NCT07899944/registered?page=2